Published in Women's Health Weekly, December 26th, 2002
Results from this NICHD-funded study of 3823 postmenopausal women were consistent with the recent Women's Health Initiative study results on continuous combined HT (defined here as estrogen combined with 25-31 days per month of progestin use). Continuous combined HT was associated with an increased breast cancer risk among current users of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.